Gene Symbol | Pearson Correlation Coefficient |
---|---|
CHPF | 0.795 |
NTM | 0.771 |
PTPRF | 0.77 |
TMEM132A | 0.769 |
NCAN | 0.755 |
OGDH | 0.751 |
DCLK2 | 0.741 |
ANO8 | 0.738 |
CRAT | 0.737 |
SCAP | 0.736 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.555 |
OR4F29 | -0.479 |
OR6C74 | -0.365 |
WDR72 | -0.359 |
GADL1 | -0.356 |
DNASE1L3 | -0.355 |
MTRNR2L6 | -0.353 |
C19orf33 | -0.35 |
FMO1 | -0.344 |
KRTAP4-5 | -0.34 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D000242 | Cyclic AMP | ADCY8 protein results in increased abundance of Cyclic AMP | 16914643 |
C015001 | arsenite | arsenite results in increased methylation of ADCY8 promoter | 23974009 |
D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ADCY8 mRNA | 18164116 |
C006780 | bisphenol A | bisphenol A results in decreased expression of ADCY8 mRNA | 25594700 |
C006780 | bisphenol A | bisphenol A results in decreased expression of ADCY8 mRNA | 25181051 |
D002220 | Carbamazepine | Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY8 protein] | 19922557 |
C026690 | cerous chloride | cerous chloride results in decreased expression of ADCY8 mRNA | 23573234 |
D002713 | Chlorine | [Ozone co-treated with Chlorine] results in increased expression of ADCY8 mRNA | 18636392 |
D003042 | Cocaine | Cocaine affects the expression of ADCY8 mRNA | 20187946 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of ADCY8 mRNA | 20106945 |
D003907 | Dexamethasone | [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of ADCY8 mRNA | 29288687 |
D003976 | Diazinon | Diazinon results in decreased expression of ADCY8 mRNA | 17452286 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ADCY8 mRNA | 18164116 |
D000431 | Ethanol | Ethanol results in increased expression of ADCY8 mRNA | 20655511 |
D005473 | Fluoxetine | Fluoxetine results in decreased expression of ADCY8 mRNA | 17033635 |
D004397 | Fonofos | Fonofos results in increased methylation of ADCY8 promoter | 22847954 |
C004312 | glycidol | glycidol results in decreased expression of ADCY8 mRNA | 24915197 |
D015056 | 1-Methyl-3-isobutylxanthine | [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of ADCY8 mRNA | 29288687 |
D007649 | Ketamine | Ketamine results in decreased expression of ADCY8 mRNA | 20080153 |
D007854 | Lead | Lead affects the expression of ADCY8 mRNA | 28903495 |
C008261 | lead acetate | lead acetate results in increased expression of ADCY8 mRNA | 20542052 |
C008261 | lead acetate | lead acetate results in increased expression of ADCY8 mRNA | 11578147 |
C432503 | licarin A | [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of ADCY8 mRNA | 29288687 |
C018091 | maduramicin | maduramicin results in decreased expression of ADCY8 mRNA | 29128925 |
D009020 | Morphine | ADCY8 protein affects the susceptibility to Morphine | 16914643 |
D009020 | Morphine | [ADCY8 protein co-treated with ADCY1 protein] affects the susceptibility to Morphine | 16914643 |
D009020 | Morphine | Morphine affects the expression of ADCY8 mRNA | 15829634 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of ADCY8 mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of ADCY8 mRNA" | 25554681 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of ADCY8 mRNA | 24236059 |
D010126 | Ozone | [Ozone co-treated with Chlorine] results in increased expression of ADCY8 mRNA | 18636392 |
D010278 | Parathion | Parathion results in increased methylation of ADCY8 promoter | 22847954 |
D010705 | Phosgene | Phosgene affects the expression of ADCY8 mRNA | 16300373 |
D011441 | Propylthiouracil | Propylthiouracil results in increased expression of ADCY8 mRNA | 24780913 |
C071262 | SK&F 82958 | Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY8 protein] | 19922557 |
C071262 | SK&F 82958 | [SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY8 protein | 19922557 |
D053260 | Soot | Soot results in decreased expression of ADCY8 mRNA | 26551751 |
C012568 | terbufos | terbufos results in increased methylation of ADCY8 promoter | 22847954 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of ADCY8 mRNA | 20133372 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of ADCY8 mRNA | 23179753|2718838 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of ADCY8 gene | 28853863 |
C066075 | vanadium pentoxide | vanadium pentoxide affects the expression of ADCY8 mRNA | 26210822 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004016 | adenylate cyclase activity | - | TAS | - |
GO:0005524 | ATP binding | - | IEA | - |
GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity | - | TAS | 8163524 |
GO:0046872 | metal ion binding | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0003091 | renal water homeostasis | - | TAS | - |
GO:0006171 | cAMP biosynthetic process | - | IBA | 21873635 |
GO:0006171 | cAMP biosynthetic process | - | IEA | - |
GO:0007165 | signal transduction | - | TAS | 8076676 |
GO:0007186 | G-protein coupled receptor signaling pathway | - | TAS | - |
GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway | - | IBA | 21873635 |
GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway | - | TAS | - |
GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway | - | IBA | 21873635 |
GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway | - | TAS | - |
GO:0007611 | learning or memory | - | TAS | 8076676 |
GO:0007616 | long-term memory | - | IEA | - |
GO:0019933 | cAMP-mediated signaling | - | IBA | 21873635 |
GO:0071377 | cellular response to glucagon stimulus | - | TAS | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005886 | plasma membrane | - | TAS | - |
GO:0016020 | membrane | - | TAS | 8163524 |
GO:0016021 | integral component of membrane | - | IEA | - |
KEGG ID | KEGG Term |
---|---|
hsa00230 | Purine metabolism |
hsa04020 | Calcium signaling pathway |
hsa04062 | Chemokine signaling pathway |
hsa04114 | Oocyte meiosis |
hsa04270 | Vascular smooth muscle contraction |
hsa04540 | Gap junction |
hsa04720 | Long-term potentiation |
hsa04742 | Taste transduction |
hsa04912 | GnRH signaling pathway |
hsa04914 | Progesterone-mediated oocyte maturation |
hsa04916 | Melanogenesis |
hsa04970 | Salivary secretion |
hsa04971 | Gastric acid secretion |
hsa04972 | Pancreatic secretion |
hsa04976 | Bile secretion |
hsa05414 | Dilated cardiomyopathy |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-111885 | Opioid Signalling | TAS |
R-HSA-111885 | Opioid Signalling | IEA |
R-HSA-111931 | PKA-mediated phosphorylation of CREB | TAS |
R-HSA-111933 | Calmodulin induced events | TAS |
R-HSA-111996 | Ca-dependent events | TAS |
R-HSA-111997 | CaM pathway | TAS |
R-HSA-112040 | G-protein mediated events | TAS |
R-HSA-112040 | G-protein mediated events | IEA |
R-HSA-112043 | PLC beta mediated events | TAS |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | TAS |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | IEA |
R-HSA-112315 | Transmission across Chemical Synapses | TAS |
R-HSA-112315 | Transmission across Chemical Synapses | IEA |
R-HSA-112316 | Neuronal System | TAS |
R-HSA-112316 | Neuronal System | IEA |
R-HSA-1430728 | Metabolism | TAS |
R-HSA-1489509 | DAG and IP3 signaling | TAS |
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-162582 | Signal Transduction | IEA |
R-HSA-163359 | Glucagon signaling in metabolic regulation | TAS |
R-HSA-163615 | PKA activation | TAS |
R-HSA-163685 | Integration of energy metabolism | TAS |
R-HSA-164378 | PKA activation in glucagon signalling | TAS |
R-HSA-170660 | Adenylate cyclase activating pathway | TAS |
R-HSA-170670 | Adenylate cyclase inhibitory pathway | TAS |
R-HSA-170670 | Adenylate cyclase inhibitory pathway | IEA |
R-HSA-372790 | Signaling by GPCR | TAS |
R-HSA-372790 | Signaling by GPCR | IEA |
R-HSA-381676 | Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | TAS |
R-HSA-382551 | Transport of small molecules | TAS |
R-HSA-388396 | GPCR downstream signalling | TAS |
R-HSA-388396 | GPCR downstream signalling | IEA |
R-HSA-418555 | G alpha (s) signalling events | TAS |
R-HSA-418555 | G alpha (s) signalling events | IEA |
R-HSA-418594 | G alpha (i) signalling events | TAS |
R-HSA-418594 | G alpha (i) signalling events | IEA |
R-HSA-418597 | G alpha (z) signalling events | IEA |
R-HSA-418597 | G alpha (z) signalling events | TAS |
R-HSA-422356 | Regulation of insulin secretion | TAS |
R-HSA-432040 | Vasopressin regulates renal water homeostasis via Aquaporins | TAS |
R-HSA-438064 | Post NMDA receptor activation events | TAS |
R-HSA-442720 | CREB phosphorylation through the activation of Adenylate Cyclase | TAS |
R-HSA-442755 | Activation of NMDA receptor and postsynaptic events | TAS |
R-HSA-445717 | Aquaporin-mediated transport | TAS |
R-HSA-5358351 | Signaling by Hedgehog | TAS |
R-HSA-5610787 | Hedgehog 'off' state | TAS |
R-HSA-9006925 | Intracellular signaling by second messengers | TAS |
R-HSA-977443 | GABA receptor activation | TAS |
R-HSA-977443 | GABA receptor activation | IEA |
R-HSA-977444 | GABA B receptor activation | TAS |
R-HSA-977444 | GABA B receptor activation | IEA |
R-HSA-991365 | Activation of GABAB receptors | TAS |
R-HSA-991365 | Activation of GABAB receptors | IEA |
R-HSA-997269 | Inhibition of adenylate cyclase pathway | TAS |
R-HSA-997269 | Inhibition of adenylate cyclase pathway | IEA |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
23278386 | Genetic markers of comorbid depression and alcoholism in women. (2013 Jun) | Procopio DO | Alcohol Clin Exp Res |